ADVM - Adverum Biotechnologies - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ADVM is currently covered by 5 analysts with an average price target of $-2.24. This is a potential upside of $-7.84 (-140%) from yesterday's end of day stock price of $5.6.

Adverum Biotechnologies's activity chart (see below) currently has 22 price targets and 44 ratings on display. The stock rating distribution of ADVM is 80% BUY and 20% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 68.65% with an average time for these price targets to be met of 370.92 days.

Highest price target for ADVM is $40, Lowest price target is $10, average price target is $20.4.

Most recent stock forecast was given by GRAIG SUVANNAVEJH from MIZUHO on 22-Nov-2024. First documented stock forecast 16-Jun-2015.

Currently out of the existing stock ratings of ADVM, 12 are a BUY (80%), 3 are a HOLD (20%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$16

$11.39 (247.07%)

$20

3 months 26 days ago
(22-Nov-2024)

1/3 (33.33%)

$9.96 (164.90%)

292

Buy

$30

$25.39 (550.76%)

$30

4 months 1 days ago
(19-Nov-2024)

0/4 (0%)

$23.75 (380.00%)

Hold

$10

$5.39 (116.92%)

$12

4 months 15 days ago
(05-Nov-2024)

1/3 (33.33%)

$2.28 (29.53%)

81

Buy

$40

$35.39 (767.68%)

$4

8 months 2 days ago
(18-Jul-2024)

1/5 (20%)

$30.52 (321.94%)

558

Buy

$6

$4.05 (207.69%)

$4

1 years 6 months 15 days ago
(05-Sep-2023)

4/7 (57.14%)

$4.22 (237.08%)

196

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ADVM (Adverum Biotechnologies) average time for price targets to be met?

On average it took 370.92 days on average for the stock forecasts to be realized with a an average price target met ratio 68.65

Which analyst has the current highest performing score on ADVM (Adverum Biotechnologies) with a proven track record?

CHARLES DUNCAN

Which analyst has the most public recommendations on ADVM (Adverum Biotechnologies)?

Charles Duncan works at CANTOR FITZGERALD and has 12 price targets and 8 ratings on ADVM

Which analyst is the currently most bullish on ADVM (Adverum Biotechnologies)?

Biren Amin with highest potential upside - $46.39

Which analyst is the currently most reserved on ADVM (Adverum Biotechnologies)?

Tyler Van Buren with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?